These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6388424)

  • 1. The effectiveness of isoxsuprine in patients with intermittent claudication.
    Skotnicki SH; van Gaal G; Wijn PF
    Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: a double-blind cross-over study in patients with intermittent claudication.
    Aarts PA; Banga JD; van Houwelingen HC; Heethaar RM; Sixma JJ
    Blood; 1986 May; 67(5):1474-81. PubMed ID: 3516258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ethaverine hydrochloride on the walking tolerance of patients with intermittent claudication.
    Trainor FS; Phillips RE; Michie DD; Zellner SR; Hogan L; Chubb JM
    Angiology; 1986 May; 37(5):343-51. PubMed ID: 3521401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R; Valentin A; Stöllberger C; Slany J
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
    Roekaerts F; Deleers L
    Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
    Di Perri T; Guerrini M
    Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H; Kieser M; Hölscher U
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound.
    Bernardi D; Bartoli P; Ferreri A; Geri AB; Ieri A
    Angiology; 1988 Nov; 39(11):942-52. PubMed ID: 3052183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of naftidrofuryl (Praxilene) on intermittent claudication.
    Waters KJ; Craxford AD; Chamberlain J
    Br J Surg; 1980 May; 67(5):349-51. PubMed ID: 6992910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication.
    Clyne CA; Galland RB; Fox MJ; Gustave R; Jantet GH; Jamieson CW
    Br J Surg; 1980 May; 67(5):347-8. PubMed ID: 6992909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
    Balsano F; Coccheri S; Libretti A; Nenci GG; Catalano M; Fortunato G; Grasselli S; Violi F; Hellemans H; Vanhove P
    J Lab Clin Med; 1989 Jul; 114(1):84-91. PubMed ID: 2661700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R; Bass A; Rabi I; Adar R
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of Scottish general practitioner open multicentre study of isoxsuprine (Duvadilan Retard) in the management of intermittent claudication.
    Mackenzie W; Wonnacott S
    Br J Clin Pract; 1985 Jan; 39(1):30-2. PubMed ID: 3986095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.